Press Releases

Date Title and Summary View
Toggle Summary New Data Shows Better Outcomes, Higher Quality of Life, Lower Cost of Care, and Increased Likelihood for Transplant with More Frequent Hemodialysis Using the NxStage System One
Five data presentations to be showcased at ASN Kidney Week 2016
View HTML
Toggle Summary NxStage Reports Third Quarter Financial Results; Raises Full-Year Revenue Guidance And Cuts Net Loss Guidance In Half
-- Q3'16 Revenue and Net Loss Better than Guidance Ranges-- Home Revenue Increases to $53.8 million, up 16% from Q3'15-- Full-Year Revenue Guidance Moves to High End of Previous Range; Net Loss Guidance Improves to a Range of $4 to $5 million-- Company to Launch Next Sequence of NxGen Features and Capabilities
View HTML
Toggle Summary NxStage Announces Fourth Quarter 2016 Investor Conference Schedule
LAWRENCE, Mass. , Nov. 1, 2016 /PRNewswire/ -- NxStage Medical, Inc. (Nasdaq: NXTM), a leading medical technology company focused on advancing renal care , today announced that Jeffrey H. Burbank , Founder and Chief Executive Officer, plans to participate in the following schedule of investor
View HTML
Toggle Summary NxStage Announces Publication of Journal Supplement with Major Clinical Reviews Supporting More Frequent Hemodialysis Therapy
Collection of clinical reviews in the American Journal of Kidney Diseases provides powerful resource for physicians to improve the health and well-being of dialysis patients
View HTML
Toggle Summary NxStage Highlights Innovative Nx2me Platform Data at Partners HealthCare Connected Health Symposium & Expo 2016
LAWRENCE, Mass. , Oct. 21, 2016 /PRNewswire/ -- NxStage Medical, Inc. (Nasdaq: NXTM), a leading medical technology company focused on advancing renal care, today announced that it is participating in the Partners Healthcare Connected Health Symposium and Expo today, Friday, October 21, 2016 in
View HTML
Toggle Summary NxStage® to Report Third Quarter 2016 Financial Results
LAWRENCE, Mass. , Oct. 6, 2016 /PRNewswire/ -- NxStage Medical, Inc. (Nasdaq: NXTM ), a leading medical technology company focused on advancing renal care , today announced plans to release its financial results for the third quarter ended September 30, 2016 , on Thursday, November 3, 2016 , before
View HTML
Toggle Summary NxStage and Satellite Healthcare Announce New Three-Year Home Hemodialysis Agreement that Includes Innovative Nx2me Platform
LAWRENCE, Mass. , Oct. 3, 2016 /PRNewswire/ --  NxStage Medical, Inc.  (Nasdaq: NXTM),  a leading medical technology company focused on advancing renal care , today announced a three-year agreement with Satellite Healthcare that includes NxStage's innovative Nx2me Connected Health® platform
View HTML
Toggle Summary NxStage Launches First of Many NxGen Features and Capabilities
LAWRENCE, Mass. , Aug. 8, 2016 NxStage Medical , Inc. (Nasdaq: NXTM),  a leading manufacturer of dialysis products , today announced the release of new enhanced priming features, the first of many upcoming capabilities of its next generation hemodialysis system.  The features are designed to be
View HTML
Toggle Summary NxStage Reports Second Quarter Financial Results And Raises Full-Year Revenue Guidance
-- Revenue Increases to $92.2 million, up 15% from Q2'15-- Home Revenue Increases to $51.1 million, up 14% from Q2'15-- Operating Income from Products Business Increases to $5.0 million-- Full-Year Revenue Guidance Increases to $360 to $365 million-- Company Launches First of Many NxGen Features and Capabilities
View HTML
Toggle Summary NxStage to Present at Canaccord Genuity 36th Annual Growth Conference
LAWRENCE, Mass. , Aug. 2, 2016 /PRNewswire/ --  NxStage Medical, Inc. (Nasdaq: NXTM), a leading medical technology company focused on advancing renal care, today announced that Jeffrey H. Burbank , Chief Executive Officer, and Matthew Towse , Chief Financial Officer, will present at the Canaccord
View HTML